All News

Emergency department (ED) readmission was more common than dermatology follow-up among patients with hidradenitis suppurativa (HS) within 30 and 180 days of initially presenting to the ED, with patients with Medicaid coverage and those who had an opioid prescribed were more likely to return.

Risk factors not properly addressed in patients with asymptomatic heart failure, such as high blood pressure and having diabetes or mild heart valve problems, can lead to structural heart problems or heart failure itself, noted Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.

Only 18% of US adults with cardiovascular disease (CVD) and 26% of adults at risk for CVD use wearable health devices.

Sessions at Kidney Week 2022 range from combatting medical misinformation to learning about the latest clinical advances, as well as championing health equity for patients with kidney disease.

The FDA has issued a complete response letter to Gilead Sciences, indicating that it cannot approve the company’s first-in-class investigational entry-inhibitor, bulevirtide, for the treatment of chronic hepatitis D virus infection and compensated liver disease.

Pfizer’s maternal respiratory syncytial virus (RSV) vaccine was found to be highly effective in infants' first 6 months of life; survey shows long COVID-19 is more common among women than men; some voters worry that a Republican-controlled Congress could put science and science policy on the line.

Patients with type 2 diabetes with a high to very high prognostic risk of diabetic kidney disease were more likely to have a reduced rectus femoris cross-sectional area, a measure of muscle mass in the lower body, and an increased visceral fat area.

A recent study supports the notion that non–driver mutations in essential thrombocythemia (ET) and polycythemia vera (PV) have predictive value and found that a proposed international prognostication model may be useful for Japanese patients.

Susan E. Quaggin, MD, FASN, president of the American Society of Nephrology (ASN) for the 2021-2022 term, discussed the major focuses and breakthroughs in nephrology to be presented at Kidney Week 2022, which include novel treatments for common and rare kidney diseases, as well as efforts to address disparities for transplant and care access.

The retrospective findings showed that searching for Staphylococcus aureus and its enterotoxins (SE) when initially screening patients for asthma can help with identifying a targeted treatment option by improving phenotyping and predicting comorbidities.

A significant uptick in chronic rhinosinusitis with nasal polyps (CRSwNP) among patients with comorbid asthma has been seen in the country over the past decade.

Sibel Blau, MD, president and CEO of the Quality Cancer Care Alliance (QCCA), talks about why QCCA and National Cancer Care Alliance (NCCA) launched Exigent Research.

A systematic review found that the use of mobile phones before sleeping was associated with poor sleep quality in children and adolescents aged 10 to 19 years.

A systematic review found that alternative approaches to calculating estimated glomerular filtration rate (eGFR) were worth looking into to properly account for diversity in populations.

Emerging therapies for psoriasis and psoriatic arthritis (PsA) include treatments that target interleukin (IL)-23 and IL-17, which could lead to the approval of new IL-23 and IL-17 inhibitors, as well as expanding the use of currently approved options.

The legal abortion rate has fallen 6% since the overturning of Roe v Wade; 30% of patients with COVID-19 experienced a rebound in symptoms after 2 consecutive days without; open enrollment for Affordable Care Act marketplace insurance begins this week.

Neil Goldfarb, president and CEO of Greater Philadelphia Business Coalition on Health (GPBCH), spoke on the biggest challenges facing GPBCH in advancing health care value, how national organizations are helping drive innovation, and the future role of business coalitions in the health care system.

Female physicians identified cost and access barriers to fertility care, which are especially relevant as more US women are choosing to delay childrearing.

The program, serving patients from rheumatology, dermatology, gastroenterology, allergy, and cardiology clinics, is the first of its kind within the Veterans Health Administration, researchers said.

Challenges to the care of chronic liver disease (CLD) include the burden of costs, managed and multidisciplinary care issues, and the lack of awareness for clinical guidelines.

Considerable research on diabetic ketoacidosis (DKA) risk has been published since the publication of a 2011 systematic review, warranting an updated analysis.

Joseph Alvarnas, MD, vice president of government affairs at City of Hope and chief clinical adviser of AccessHope in Duarte, California, discusses the recently passed Cancer Care Equity Act in California that provides access to clinical trials and advanced care for Medi-Cal beneficiaries.

The quest to deliver better cancer care—with better outcomes and patient experience—is not a one-size-fits-all journey, as seen in panels during the Community Oncology Alliance (COA) Payer Exchange Summit, held in Tyson’s Corner, Virginia.

This rare immune-related adverse event has only been previously reported 4 times in the context of immune checkpoint inhibitor (ICI) treatment.

Existing evidence suggests genetics, environmental factors, and exposure to specific chemicals—such as those in cigarettes—can all increase a person’s risk of systemic lupus erythematosus.

Appropriate application of telehealth could make health care delivery more efficient, explains Dr Mike Hoaglin.

Patients with young-onset Parkinson disease experience significant emotional burden that is exacerbated by unmet educational needs.

It is unclear what role treatment plays in affecting hepatocellular carcinoma (HCC) risk, the authors found.

Tom Robinson, vice president of global access at JDRF, talks about the predictive modeling exercise used to develop and refine the Type 1 Diabetes (T1D) Index.

The number of tuberculosis cases has risen by 4.5% from 2021; Black and Hispanic patients with COVID-19 were less likely to receive paxlovid in 2022; a new report highlights declines in US cancer death rates between 2015 and 2019.